X

Trial Profile

A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Renal Function

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 17 May 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apraglutide (Primary)
Indications Short bowel syndrome
Focus Pharmacokinetics
Sponsors VectivBio

Most Recent Events

11 Oct 2022 Results presented at the 30th United European Gastroenterology Week
29 Mar 2022 Results published in the VectivBio Media Release
29 Mar 2022 According to a VectivBio media release, data from this study were presented as a poster at the 2022 American Society for Parenteral and Enteral Nutrition Conference (ASPEN).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com